Skip to main content
Equibles

Legal & General Group Plc

Position in NVCR — NovoCure Ltd

CIK 764068 London, X0
Back to NVCR Full portfolio

Position in NVCR

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$4,936,005
+$1,328,794 QoQ
Shares Held
325,809
-1.5% QoQ
Ownership
0.280%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#41
of 217 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NVCR Over Time

Shares Held

Position Value (USD)

Position in Medical Devices

Healthcare · as of Jun 30, 2026

Legal & General Group Plc holds $4,263,167,333 across 73 Medical Devices names. NVCR ranks #24 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABT
Abbott Laboratories
 11,929,958 $1,082,524,387
2 MDT
Medtronic plc
 9,832,804 $769,220,255
3 SYK
Stryker Corp
 2,246,257 $707,211,552
4 BSX
Boston Scientific Corp
 10,119,264 $431,890,186
5 EW
Edwards Lifesciences Corp
 4,301,222 $389,088,541
6 GEHC
GE HealthCare Technologies Inc.
 2,771,907 $177,429,766
7 DXCM
Dexcom Inc
 2,572,193 $173,237,196
8 STE
STERIS plc
 732,322 $154,205,042

All Filings in NVCR

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,936,005 325,809
2026-03-31 $3,607,211 330,937
2025-12-31 $5,258,163 406,664
2025-09-30 $3,172,749 245,569
2025-06-30 $3,464,822 194,653
2025-03-31 $2,931,673 164,516
2024-12-31 $4,701,187 157,758
2024-09-30 $2,882,358 184,412
2024-06-30 $2,950,658 172,251
2024-03-31 $2,642,594 169,072
2023-12-31 $2,874,143 192,508
2023-09-30 $2,887,683 178,804
2023-06-30 $21,232,562 511,628
2023-03-31 $26,553,734 441,532
2022-12-31 $36,837,763 502,219
2022-09-30 $40,846,392 537,594
2022-06-30 $39,960,136 574,966
2022-03-31 $43,654,906 526,915
2021-12-31 $42,340,389 563,937
2021-09-30 $65,253,269 561,705
2021-06-30 $123,008,283 554,541
2021-03-31 $68,685,617 519,637
2020-12-31 $51,217,070 295,984
2020-09-30 $10,371,086 93,173
2020-06-30 $5,357,102 90,339
2020-03-31 $3,998,310 59,375